218 A case of Toxic Epidermal Necrolysis secondary to combination Ipilimumab and Nivolumab therapy for Pleural Mesothelioma, successfully treated with Ruxolitinib

Judy Tabbakh; Racha Kussaibati; Francesca Kinsella; Gary Middleton; Victoria Kunene; Sawsan Elsheikh; Claudia Roberts; Darren Lewis; Rachel Powell; Ser-Ling Chua; Shobhit Baijal

doi:10.1016/j.lungcan.2024.107779

218 A case of Toxic Epidermal Necrolysis secondary to combination Ipilimumab and Nivolumab therapy for Pleural Mesothelioma, successfully treated with Ruxolitinib

Judy Tabbakh, Racha Kussaibati, Francesca Kinsella, Gary Middleton, Victoria Kunene, Sawsan Elsheikh, Claudia Roberts, Darren Lewis, Rachel Powell, Ser-Ling Chua, Shobhit Baijal

Immunology and Immunotherapy

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Article number	107779
Number of pages	1
Journal	Lung Cancer
Volume	190
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/j.lungcan.2024.107779
Publication status	Published - 17 Apr 2024
Event	22nd BTOG Annual Conference 2024 - ICC Belfast , Belfast, United Kingdom Duration: 17 Apr 2024 → 19 Apr 2024

Access to Document

10.1016/j.lungcan.2024.107779Licence: None: All rights reserved

Cite this

Tabbakh, J., Kussaibati, R., Kinsella, F., Middleton, G., Kunene, V., Elsheikh, S., Roberts, C., Lewis, D., Powell, R., Chua, S.-L., & Baijal, S. (2024). 218 A case of Toxic Epidermal Necrolysis secondary to combination Ipilimumab and Nivolumab therapy for Pleural Mesothelioma, successfully treated with Ruxolitinib. Lung Cancer, 190(Supplement 1), Article 107779. https://doi.org/10.1016/j.lungcan.2024.107779

@article{5fd0ffddbeb444b8a1af2b300617435a,

title = "218 A case of Toxic Epidermal Necrolysis secondary to combination Ipilimumab and Nivolumab therapy for Pleural Mesothelioma, successfully treated with Ruxolitinib",

author = "Judy Tabbakh and Racha Kussaibati and Francesca Kinsella and Gary Middleton and Victoria Kunene and Sawsan Elsheikh and Claudia Roberts and Darren Lewis and Rachel Powell and Ser-Ling Chua and Shobhit Baijal",

year = "2024",

month = apr,

day = "17",

doi = "10.1016/j.lungcan.2024.107779",

language = "English",

volume = "190",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier",

number = "Supplement 1",

note = "22nd BTOG Annual Conference 2024, BTOG24 ; Conference date: 17-04-2024 Through 19-04-2024",

}

Tabbakh, J, Kussaibati, R, Kinsella, F, Middleton, G, Kunene, V, Elsheikh, S, Roberts, C, Lewis, D, Powell, R, Chua, S-L & Baijal, S 2024, '218 A case of Toxic Epidermal Necrolysis secondary to combination Ipilimumab and Nivolumab therapy for Pleural Mesothelioma, successfully treated with Ruxolitinib', Lung Cancer, vol. 190, no. Supplement 1, 107779. https://doi.org/10.1016/j.lungcan.2024.107779

TY - JOUR

T1 - 218 A case of Toxic Epidermal Necrolysis secondary to combination Ipilimumab and Nivolumab therapy for Pleural Mesothelioma, successfully treated with Ruxolitinib

AU - Tabbakh, Judy

AU - Kussaibati, Racha

AU - Kinsella, Francesca

AU - Middleton, Gary

AU - Kunene, Victoria

AU - Elsheikh, Sawsan

AU - Roberts, Claudia

AU - Lewis, Darren

AU - Powell, Rachel

AU - Chua, Ser-Ling

AU - Baijal, Shobhit

PY - 2024/4/17

Y1 - 2024/4/17

U2 - 10.1016/j.lungcan.2024.107779

DO - 10.1016/j.lungcan.2024.107779

M3 - Abstract

SN - 0169-5002

VL - 190

JO - Lung Cancer

JF - Lung Cancer

IS - Supplement 1

M1 - 107779

T2 - 22nd BTOG Annual Conference 2024

Y2 - 17 April 2024 through 19 April 2024

ER -